GL1X · GenesisL1 explorer

Research workbench

Cryoem structure of the human separase-CDK1-cyclin B1-CKS1 complex

Analyse Cryoem structure of the human separase-CDK1-cyclin B1-CKS1 complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NJ0
Type
protein
Length
1,818 residues
Chains
4
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O95997, Q14674, P06493, P14635, P61024
Ligands
PO4

Structure

electron microscopy · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein1188—O95997, Q14674
B—protein290—P06493
C—protein270—P14635
D—protein70—P61024

Ligands and binding sites

  • PO4 · Phosphate ion · ion · chains D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7NJ0 · CryoEM structure of the human Separase-Cdk1-cyclin B1-Cks1 complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P14635 · AlphaFold monomer V2.0 prediction for G2/MITOTIC-specific cyclin-B1 (P14635) · a predicted model of the same protein · chain C against A, TM-score 0.99
  • Q14674 · AlphaFold monomer V2.0 prediction for separin (Q14674) · a predicted model of the same protein · chain A against A, TM-score 0.95
  • P61024 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinases regulatory subunit 1… · a predicted model of the same protein · chain D against A, TM-score 0.94
  • P06493 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 1 (P06493) · a predicted model of the same protein · chain B against A, TM-score 0.91
  • O95997 · AlphaFold monomer V2.0 prediction for securin (O95997) · a predicted model of the same protein · chain A against A, TM-score 0.07

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.